R D Nipp1, A El-Jawahri2, J N Fishbein3, E R Gallagher2, J M Stagl3, E R Park3, V A Jackson4, W F Pirl3, J A Greer3, J S Temel2. 1. Department of Medicine, Division of Hematology and Oncology rnipp@mgh.harvard.edu. 2. Department of Medicine, Division of Hematology and Oncology. 3. Department of Psychiatry. 4. Department of Medicine, Division of Palliative Care, Massachusetts General Hospital and Harvard Medical School, Boston, USA.
Abstract
BACKGROUND: Family caregivers (FCs) are critically important for patients with cancer, yet they may experience psychological distress related to caregiving demands. We sought to describe rates of depression and anxiety in FCs of patients with incurable cancer and identify factors associated with these symptoms to determine those at greatest risk for psychological distress. PATIENTS AND METHODS: We performed a cross-sectional analysis of baseline data from a randomized trial of early palliative care. We assessed depression and anxiety using the Hospital Anxiety and Depression Scale in patients within 8 weeks of diagnosis of incurable lung or gastrointestinal cancer and their FCs. We also assessed patients' quality of life (Functional Assessment of Cancer Therapy-General), coping strategies (Brief COPE), and their report of the primary goal of their cancer treatment. We used linear regression with purposeful selection of covariates to identify factors associated with FC depression and anxiety symptoms. RESULTS:We enrolled 78.6% (n = 275) of potentially eligible FCs. The majority were female (69.1%) and married to the patient (66.2%). While the proportion of FCs and patients reporting depression did not differ (16.4% versus 21.5%, P = 0.13), FCs were more likely to report anxiety compared with patients (42.2% versus 28.4%, P < 0.001). Patients' use of acceptance coping was associated with lower FC depression (B = -0.42, P < 0.001), while emotional support coping was associated with higher FC depression (B = 0.69, P = 0.001) and lower FC anxiety (B = -0.70, P < 0.001). Patient report that their primary goal of their treatment was to 'cure my cancer' was associated with higher FC depression (B = 0.72, P = 0.03). CONCLUSIONS:Patients with incurable cancer and their FCs report high levels of depression and anxiety symptoms. We demonstrated that patients' coping strategies and prognostic understanding were associated with FC depression and anxiety symptoms, underscoring the importance of targeting these risk factors when seeking to address the psychological distress experienced by FCs.
RCT Entities:
BACKGROUND: Family caregivers (FCs) are critically important for patients with cancer, yet they may experience psychological distress related to caregiving demands. We sought to describe rates of depression and anxiety in FCs of patients with incurable cancer and identify factors associated with these symptoms to determine those at greatest risk for psychological distress. PATIENTS AND METHODS: We performed a cross-sectional analysis of baseline data from a randomized trial of early palliative care. We assessed depression and anxiety using the Hospital Anxiety and Depression Scale in patients within 8 weeks of diagnosis of incurable lung or gastrointestinal cancer and their FCs. We also assessed patients' quality of life (Functional Assessment of Cancer Therapy-General), coping strategies (Brief COPE), and their report of the primary goal of their cancer treatment. We used linear regression with purposeful selection of covariates to identify factors associated with FC depression and anxiety symptoms. RESULTS: We enrolled 78.6% (n = 275) of potentially eligible FCs. The majority were female (69.1%) and married to the patient (66.2%). While the proportion of FCs and patients reporting depression did not differ (16.4% versus 21.5%, P = 0.13), FCs were more likely to report anxiety compared with patients (42.2% versus 28.4%, P < 0.001). Patients' use of acceptance coping was associated with lower FC depression (B = -0.42, P < 0.001), while emotional support coping was associated with higher FC depression (B = 0.69, P = 0.001) and lower FC anxiety (B = -0.70, P < 0.001). Patient report that their primary goal of their treatment was to 'cure my cancer' was associated with higher FC depression (B = 0.72, P = 0.03). CONCLUSIONS:Patients with incurable cancer and their FCs report high levels of depression and anxiety symptoms. We demonstrated that patients' coping strategies and prognostic understanding were associated with FC depression and anxiety symptoms, underscoring the importance of targeting these risk factors when seeking to address the psychological distress experienced by FCs.
Authors: Areej El-Jawahri; Lara Traeger; Elyse R Park; Joseph A Greer; William F Pirl; Inga T Lennes; Vicki A Jackson; Emily R Gallagher; Jennifer S Temel Journal: Cancer Date: 2013-10-10 Impact factor: 6.860
Authors: Eric S Zhou; Frank J Penedo; Natalie E Bustillo; Catherine Benedict; Mikal Rasheed; Suzanne Lechner; Mark Soloway; Bruce R Kava; Neil Schneiderman; Michael H Antoni Journal: J Support Oncol Date: 2010 Sep-Oct
Authors: Boyoung Park; So Young Kim; Ji-Yeon Shin; Robert W Sanson-Fisher; Dong Wook Shin; Juhee Cho; Jong-Hyock Park Journal: Support Care Cancer Date: 2013-06-01 Impact factor: 3.603
Authors: J Nicholas Dionne-Odom; Wendy Demark-Wahnefried; Richard A Taylor; Gabrielle B Rocque; Andres Azuero; Aras Acemgil; Michelle Y Martin; Meka Astin; Deborah Ejem; Elizabeth Kvale; Karen Heaton; Maria Pisu; Edward E Partridge; Marie A Bakitas Journal: Support Care Cancer Date: 2017-03-01 Impact factor: 3.603
Authors: Joseph A Greer; Allison J Applebaum; Juliet C Jacobsen; Jennifer S Temel; Vicki A Jackson Journal: J Clin Oncol Date: 2020-02-05 Impact factor: 44.544
Authors: Karla T Washington; Debra Parker Oliver; Jacquelyn J Benson; Abigail J Rolbiecki; Lucas A Jorgensen; Dulce M Cruz-Oliver; George Demiris Journal: J Psychosoc Oncol Date: 2019-11-06
Authors: Georgia K B Halkett; Elizabeth A Lobb; Thèrése Shaw; Michelle M Sinclair; Lisa Miller; Elizabeth Hovey; Anna K Nowak Journal: Support Care Cancer Date: 2016-11-14 Impact factor: 3.603
Authors: Ryan D Nipp; Joseph A Greer; Areej El-Jawahri; Samantha M Moran; Lara Traeger; Jamie M Jacobs; Juliet C Jacobsen; Emily R Gallagher; Elyse R Park; David P Ryan; Vicki A Jackson; William F Pirl; Jennifer S Temel Journal: J Clin Oncol Date: 2017-06-02 Impact factor: 44.544
Authors: Heather M Derry; Andrew S Epstein; Wendy G Lichtenthal; Holly G Prigerson Journal: Expert Rev Anticancer Ther Date: 2019-08-10 Impact factor: 4.512
Authors: Kelly M Trevino; Paul K Maciejewski; Megan Johnson Shen; Holly G Prigerson; Supriya Mohile; Charles Kamen; Ronald M Epstein; Paul Duberstein Journal: Support Care Cancer Date: 2018-11-01 Impact factor: 3.603
Authors: Deborah A Forst; Kit Quain; Sophia L Landay; Maya Anand; Emilia Kaslow-Zieve; Michelle M Mesa; Jamie M Jacobs; Jorg Dietrich; Michael W Parsons; Nora Horick; Joseph A Greer; Tracy T Batchelor; Vicki A Jackson; Areej El-Jawahri; Jennifer S Temel Journal: Neurooncol Pract Date: 2020-04-17
Authors: Tamryn F Gray; Deborah Forst; Ryan D Nipp; Joseph A Greer; Jennifer S Temel; Areej El-Jawahri Journal: J Palliat Med Date: 2020-09-30 Impact factor: 2.947